Doctors: Avandia Prescriptions Declined Before FDA Ruling

The Food and Drug Administration unveiled the recently updated norms for the diabetes drug Avandia.

The norms can be used in case of type 2 patients and comes in form of "drug of last resort" for those patients.

Avandia which is considered to be associated with heart attacks and stroke will soon be withdrawn out of the market soon after FDA's move.

The drug will be taking the safety measures of US and health experts will be steering patients, until Avandia comes as the only left out option.


Flu Vaccine is Free from Narcolepsy: EMA

On Thursday, the European drug regulators at the European Medicines Agency (EMA) stated that the news linking Pandemrix, the H1N1 swine flu vaccine manufactured by GlaxoSmithKline, to narcolepsy was not at all true. According to the EMA, there has been no evidence that Pandemrix led to any cases of narcolepsy or any sleeping disorders, yet the investigation would still continue for duration of three to six months, in order to confirm the results. The investigations were conducted by Committee for Medicinal Products for Human Use.


Kidney Cancer Drug May Help Treat Thyroid Cancer

The medical journal, The Lancet Oncology has reported the recent phase II clinical trial, which suggests that the drug Pazopanib or Votrient made by GlaxoSmithKline and used for the treatment of kidney cancer may also be used for the treatment of thyroid cancer.

According to the trial, a good result was observed by the researchers when 49% of the patients showed a significant response towards Pazopanib. Besides this the response lasted longer more than a year in about two third of the patients.


Glaxo to Shell £1.6bn to Solve its Legal Woes

GlaxoSmithKline, the famous drugs giant, yesterday announced that it extended an estimated £1.57bn worth charge in a view to reconcile a string of disputes over its controversial Avandia diabetes treatment and other drugs, witnessed in the second quarter.

Europe's biggest pharmaceutical Company has been facing a series of longstanding woes including charges that has linked its diabetic drug Avandia to cardiovascular problem.

In addition, the Company posted that the second-quarter charge requires addressing a string of liability cases relating to its Paxil anti-depressant drug, as well.


Glaxo Inflicted By Legal Charges

GlaxoSmithKline is facing hard days in its second quarter. The company has set aside a sum of 1.57 billion-Pound, in order to compensate with the legal charges inflicted on it, which claims that the drug Avandia, produced by the company, poses side effects such as heart attacks.

The legal charges against the company include product-liability and antitrust cases concerning Paxil antidepressant, lawsuits against Avandia and other products. After deduction of the tax, the charge cost around 1.35 billion Pounds.



Subscribe to RSS - GlaxoSmithKline